CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-13 | Catinazzo Thomas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2026-01-06 | Patel Sanjiv President and CEO | Sale | −43,168 | $7.82 | $338K | 661,041 |
| 2025-12-31 | Rahmer Peter See remarks | Grant or award | +994 | $2.99 | $3K | 338,463 |
| 2025-12-31 | Patel Sanjiv President and CEO | Grant or award | +994 | $2.99 | $3K | 704,209 |
| 2025-11-04 | COATS LONNEL Director | Grant or award · Stock Option (Right to Buy) | +207,931 | 207,931 | ||
| 2025-11-04 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +207,931 | 207,931 | ||
| 2025-11-03 | Patel Sanjiv President and CEO | Sale | −62,073 | $7.00 | $435K | 703,215 |
| 2025-10-29 | Rahmer Peter See remarks | Sale | −21,394 | $7.50 | $160K | 337,469 |
| 2025-10-28 | Rahmer Peter See remarks | Sale | −19,135 | $7.29 | $139K | 358,863 |
| 2025-10-28 | Catinazzo Thomas Chief Financial Officer | Sale | −21,664 | $7.29 | $158K | 313,631 |
| 2025-10-28 | Bergstrom Donald A President, R&D | Sale | −30,897 | $7.29 | $225K | 521,823 |
| 2025-07-29 | Rahmer Peter See remarks | Sale | −15,724 | $3.68 | $58K | 377,998 |
| 2025-07-29 | Catinazzo Thomas Chief Financial Officer | Sale | −18,380 | $3.68 | $68K | 335,295 |
| 2025-07-29 | Bergstrom Donald A President, R&D | Sale | −26,701 | $3.68 | $98K | 552,720 |
| 2025-07-29 | Adams Brian Chief Legal Officer | Sale | −18,276 | $3.68 | $67K | 371,472 |
| 2025-07-28 | Rahmer Peter See remarks | Sale | −1,359 | $3.74 | $5K | 393,722 |
| 2025-07-28 | Catinazzo Thomas Chief Financial Officer | Sale | −1,701 | $3.74 | $6K | 353,675 |
| 2025-07-28 | Bergstrom Donald A President, R&D | Sale | −4,069 | $3.74 | $15K | 579,421 |
| 2025-07-28 | Adams Brian Chief Legal Officer | Sale | −1,637 | $3.74 | $6K | 389,748 |
| 2025-07-09 | Patel Sanjiv President and CEO | Sale | −42,740 | $3.57 | $153K | 783,927 |
Page 4 of 17 · 329 trades